Literature DB >> 29600191

Late onset acute Vogt-Koyanagi-Harada syndrome-challenges on the way.

Sandra Rodrigues-Barros1, Jacqueline Martins Sousa2, Bruno Carvalho3, Gabriel Andrade2, Heloísa Nascimento2.   

Abstract

Year:  2018        PMID： 29600191      PMCID： PMC5861247          DOI： 10.18240/ijo.2018.03.27

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  15 in total

Review 1.  Vogt-Koyanagi-Harada disease.

Authors:  Ghazala A Datoo O'Keefe; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2016-05-27       Impact factor: 6.048

2.  The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.

Authors:  Ahmed M Abu El-Asrar; Suhail Hemachandran; Hani S Al-Mezaine; Dustan Kangave; Abdulrahman M Al-Muammar
Journal:  Acta Ophthalmol       Date:  2012-09-12       Impact factor: 3.761

3.  Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease.

Authors:  Yoshikatsu Hosoda; Hisako Hayashi; Shoji Kuriyama
Journal:  Br J Ophthalmol       Date:  2015-03-19       Impact factor: 4.638

4.  Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.

Authors:  Chiharu Iwahashi; Kensuke Okuno; Noriyasu Hashida; Kei Nakai; Nobuyuki Ohguro; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2015-03-26       Impact factor: 2.447

5.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

6.  Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years.

Authors:  Yumiko Yamamoto; Atsuki Fukushima; Koji Nishino; Yuji Koura; Tsutomu Komatsu; Hisayuki Ueno
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

7.  Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.

Authors:  T Y Y Lai; R P S Chan; C K M Chan; D S C Lam
Journal:  Eye (Lond)       Date:  2008-03-28       Impact factor: 3.775

8.  Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.

Authors:  Elizabeth Shen; Sivakumar R Rathinam; Manohar Babu; Anuradha Kanakath; Radhika Thundikandy; Salena M Lee; Erica N Browne; Travis C Porco; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2016-06-10       Impact factor: 5.258

9.  Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.

Authors:  Tatsushi Kawaguchi; Shintaro Horie; Nadia Bouchenaki; Kyoko Ohno-Matsui; Manabu Mochizuki; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-01-17       Impact factor: 2.031

10.  Vogt-Koyanagi-Harada disease in elderly Japanese patients.

Authors:  Chihiro Kiyomoto; Masamoto Imaizumi; Kenichi Kimoto; Hiromi Abe; Satoko Nakano; Kazuo Nakatsuka
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.